Research programme: enzymes and enzyme-related compounds - EnzymeBioSystems

Drug Profile

Research programme: enzymes and enzyme-related compounds - EnzymeBioSystems

Latest Information Update: 30 Jul 2015

Price : $50

At a glance

  • Originator Enzyme Bio-Systems
  • Class Enzymes; Triterpenes
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Breast cancer; Cancer; Colorectal cancer

Most Recent Events

  • 27 Jul 2015 EnzymeBioSystems announces intention to submit IND application to the US FDA for the Breast cancer prevention
  • 10 Dec 2014 Preclinical trials in Colorectal cancer in USA (unspecified route)
  • 17 Nov 2014 Preclinical trials in Breast cancer prevention in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top